0

RK-682

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP150627375
CAS150627-37-5
MDL NumberMFCD20488046
Molecular Weight368.51
InChI KeyKZTSLHQKWLYYAC-GOSISDBHSA-N
Description≥98% (HPLC)
SolubilityDMSO, heptane and xylene: ≥8 mg/mL
Assay≥98% (HPLC)
Colorwhite to tan
Formpowder
Size200μG, 1MG
Storage Conditions−20°C
1

Design and Synthesis of a Dimeric Derivative of RK-682 With Increased Inhibitory Activity Against VHR, a Dual-Specificity ERK Phosphatase: Implications for the Molecular Mechanism of the Inhibition

T Usui, S Kojima, S Kidokoro, K Ueda, H Osada, M Sodeoka

Chem Biol. 2001 Dec;8(12):1209-20.

PMID: 11755399

1

In Vitro Reconstruction of Tetronate RK-682 Biosynthesis

Yuhui Sun, Frank Hahn, Yuliya Demydchuk, James Chettle, Manuela Tosin, Hiroyuki Osada, Peter F Leadlay

Nat Chem Biol. 2010 Feb;6(2):99-101.

PMID: 20081823

1

Is RK-682 a Promiscuous Enzyme Inhibitor? Synthesis and in Vitro Evaluation of Protein Tyrosine Phosphatase Inhibition of Racemic RK-682 and Analogues

Vânia M T Carneiro, Daniela B B Trivella, Valéria Scorsato, Viviane L Beraldo, Mariana P Dias, Tiago J P Sobreira, Ricardo Aparicio, Ronaldo A Pilli

Eur J Med Chem. 2015 Jun 5;97:42-54.

PMID: 25938987

1

RK-682, a Potent Inhibitor of Tyrosine Phosphatase, Arrested the Mammalian Cell Cycle Progression at G1phase

T Hamaguchi, T Sudo, H Osada

FEBS Lett. 1995 Sep 18;372(1):54-8.

PMID: 7556642

1

Structure-based Design of a Selective Heparanase Inhibitor as an Antimetastatic Agent

Keisuke Ishida, Go Hirai, Koji Murakami, Takayuki Teruya, Siro Simizu, Mikiko Sodeoka, Hiroyuki Osada

Mol Cancer Ther. 2004 Sep;3(9):1069-77.

PMID: 15367701

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode